Pilot Clinical Trial (Phase II) of Inquiry-based Stress Reduction (IBSR) Program for Survivors of Breast Cancer
|ClinicalTrials.gov Identifier: NCT01244087|
Recruitment Status : Completed
First Posted : November 19, 2010
Last Update Posted : June 14, 2013
The IBSR (Inquiry-based stress reduction) intervention, developed by Byron Katie (www.thework.com), trains subjects to reduce their perceived level of stress by self-inquiry of their thoughts and beliefs connected to stressful circumstances or symptoms. This meditative process, named "The Work", enables the participants to identify and question the stressful thoughts that cause their suffering. The core of IBSR is simply four questions and a turnaround, which is a way of experiencing the opposite of what the participant believes. This process is simple, powerful and can be easily implemented in daily life.
Therefore, on the basis of previous data and beneficial observations the investigators postulate that the clinical utility of IBSR mediation program may improve psychological and physical symptoms and quality of life among BC patients during the survivorship period. Thus, we will conduct a pilot/feasibility randomized controlled clinical trial designed to
- Assess feasibility of a IBSR intervention by examining attendance, drop-out rates, and program satisfaction.
- Determine whether IBSR intervention compared with usual care is efficacious in improving quality of life, psychological and physical status in BC survivors.
|Condition or disease|
|Inquiry Based Stress Reduction|
Show Detailed Description
|Study Type :||Observational|
|Estimated Enrollment :||30 participants|
|Official Title:||Pilot Clinical Trial (Phase II) of Inquiry-based Stress Reduction (IBSR) Program for Survivors of Breast Cancer|
|Study Start Date :||December 2010|
|Primary Completion Date :||December 2011|
|Study Completion Date :||May 2013|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01244087
|Sourasky M.C.Oncology Department|
|Tel Aviv, Israel, 64239|
|Principal Investigator:||Ilan Ron, MD||Sourasky M.C.|